Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Dose Capping Enoxaparin Is Unjustified and Denies...
Journal article

Dose Capping Enoxaparin Is Unjustified and Denies Patients With Acute Coronary Syndromes a Potentially Effective Treatment

Authors

Spinler SA; Dobesh P

Journal

Chest, Vol. 127, No. 6, pp. 2288–2289

Publisher

Elsevier

Publication Date

6 2005

DOI

10.1378/chest.127.6.2288

ISSN

0012-3692

Associated Experts

James Demetrios Douketis

Professor, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

3214 Pharmacology and Pharmaceutical Sciences32 Biomedical and Clinical Sciences3201 Cardiovascular medicine and haematology3202 Clinical sciences

Medical Subject Headings (MeSH)

Acute DiseaseAngina, UnstableAnticoagulantsBiological AvailabilityClinical Trials as TopicDose-Response Relationship, DrugDrug Administration ScheduleEnoxaparinFemaleFollow-Up StudiesHumansMaleMaximum Tolerated DoseMyocardial InfarctionRisk AssessmentSeverity of Illness IndexSurvival AnalysisTreatment Outcome
View published work (Non-McMaster Users)
View published work (McMaster Users)